ClinicalTrials.Veeva

Menu

Hydrodissection of the Hepatoduodenal Ligament (Duodenal)

U

University Hospital, Strasbourg, France

Status

Enrolling

Conditions

Hepatic Lesions

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Percutaneous treatment of liver lesions adjacent to the duodenum exposes the duodenum to the risk of thermal injury, limiting removal and oncologic outcome. In this study the investigators investigate the feasibility of hepato duodenal ligament dissection in the percutaneous treatment of liver lesions adjacent to the duodenum.

Enrollment

13 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Major subject (≥18 years of age)
  • Subject who underwent percutaneous ablation of primary or secondary liver lesions at HUS that required per-procedure hepatoduodenal ligament hydrodissection in the interventional imaging department of the New Civil Hospital from January 2019 to July 2022.
  • Subject who has not expressed opposition to the reuse of their data for the purpose of this research.

Exclusion criteria

  • Opposition to the reuse of his/her data for the purpose of scientific research.

Trial contacts and locations

1

Loading...

Central trial contact

Julien GARNON, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems